Japanese Pharma Assessing Damage To Plants Amidst Country's Largest National Disaster; Production Delays Expected

TOKYO - Following a massive earthquake, tsunami, and potential nuclear disaster, Japan's leading pharmaceutical companies like Astellas Pharma Inc. are joining the rest of the country in assessing the damage, and taking stock of what needs to be done versus what can be done